Livforsakringsbolaget Skandia’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Livforsakringsbolaget Skandia's ABMD Position: Q4 2022 in Review
Livforsakringsbolaget Skandia sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 100 shares — an estimated $25K sold.
Livforsakringsbolaget Skandia first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $245K in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Livforsakringsbolaget Skandia reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Livforsakringsbolaget Skandia sold 100 Abiomed Inc shares in Q4 2022, an estimated $25K.
- Livforsakringsbolaget Skandia first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- Livforsakringsbolaget Skandia's Abiomed Inc position peaked at $245K in Q2 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.